97 related articles for article (PubMed ID: 37459055)
41. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
[TBL] [Abstract][Full Text] [Related]
42. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
Churilla T; Egleston B; Dong Y; Shaikh T; Murphy C; Mantia-Smaldone G; Chu C; Rubin S; Anderson P
Gynecol Oncol; 2016 Jun; 141(3):516-523. PubMed ID: 27012428
[TBL] [Abstract][Full Text] [Related]
43. Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers.
Zheng X; Gu H; Cao X; Pan B; Xiang H; Ju M; Xu S; Zheng M
Front Immunol; 2023; 14():1113369. PubMed ID: 36875089
[TBL] [Abstract][Full Text] [Related]
44. Breast and Cervical Cancer Screening Among Medicaid Beneficiaries: The Role of Physician Payment and Managed Care.
Sabik LM; Dahman B; Vichare A; Bradley CJ
Med Care Res Rev; 2020 Feb; 77(1):34-45. PubMed ID: 29726303
[TBL] [Abstract][Full Text] [Related]
45. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
Simeone JC; Marcoux RM; Quilliam BJ
J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
[TBL] [Abstract][Full Text] [Related]
46. Adverse event-related costs for systemic metastatic breast cancer treatment among female Medicaid beneficiaries.
Irwin DE; Masaquel A; Johnston S; Barnett B
J Med Econ; 2016 Nov; 19(11):1027-1033. PubMed ID: 27206801
[TBL] [Abstract][Full Text] [Related]
47. Assessing the effectiveness of Medicaid in breast and cervical cancer prevention.
Koroukian SM
J Public Health Manag Pract; 2003; 9(4):306-14. PubMed ID: 12836513
[TBL] [Abstract][Full Text] [Related]
48. No improvement in survival of older women with cervical cancer-A nationwide study.
Wenzel HHB; Bekkers RLM; Lemmens VEPP; Van der Aa MA; Nijman HW
Eur J Cancer; 2021 Jul; 151():159-167. PubMed ID: 33993062
[TBL] [Abstract][Full Text] [Related]
49. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
50. Hazard of Cervical, Oropharyngeal, and Anal Cancers in HIV-Infected and HIV-Uninfected Medicaid Beneficiaries.
Michaud JM; Zhang T; Shireman TI; Lee Y; Wilson IB
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1447-1457. PubMed ID: 32385117
[TBL] [Abstract][Full Text] [Related]
51. Medicaid managed care: are academic medical centers penalized by attracting patients with high-cost conditions?
Heisler M; DeMonner SM; Billi JE; Hayward RA
Am J Manag Care; 2003 Jan; 9(1):19-29. PubMed ID: 12549812
[TBL] [Abstract][Full Text] [Related]
52. Area-Level Predictors of Medication Nonadherence Among US Medicaid Beneficiaries With Lupus: A Multilevel Study.
Feldman CH; Costenbader KH; Solomon DH; Subramanian SV; Kawachi I
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):903-913. PubMed ID: 30055088
[TBL] [Abstract][Full Text] [Related]
53. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
54. Patterns of HIV testing among women diagnosed with invasive cervical cancer in the New Jersey Medicaid Program.
McGee-Avila JK; Doose M; Nova J; Kumar R; Stroup AM; Tsui J
Cancer Causes Control; 2020 Oct; 31(10):931-941. PubMed ID: 32803402
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of Medicaid managed care. Satisfaction, access, and use.
Sisk JE; Gorman SA; Reisinger AL; Glied SA; DuMouchel WH; Hynes MM
JAMA; 1996 Jul; 276(1):50-5. PubMed ID: 8667539
[TBL] [Abstract][Full Text] [Related]
56. An evaluation of a Medicaid expansion for cancer care: The Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Lantz PM; Soliman S
Womens Health Issues; 2009; 19(4):221-31. PubMed ID: 19589471
[TBL] [Abstract][Full Text] [Related]
57. Association of Physician Densities and Gynecologic Cancer Outcomes in the United States.
Smick AH; Holbert M; Neff R
Obstet Gynecol; 2022 Nov; 140(5):751-757. PubMed ID: 36201771
[TBL] [Abstract][Full Text] [Related]
58. Effect of expansions in state Medicaid eligibility on access to care and the use of emergency department services for adult Medicaid enrollees.
Ndumele CD; Mor V; Allen S; Burgess JF; Trivedi AN
JAMA Intern Med; 2014 Jun; 174(6):920-6. PubMed ID: 24710866
[TBL] [Abstract][Full Text] [Related]
59. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.
Islami F; Fedewa SA; Jemal A
Prev Med; 2019 Jun; 123():316-323. PubMed ID: 31002830
[TBL] [Abstract][Full Text] [Related]
60. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
